Validity of ICU Clinician's Appraisal of Proportionality in CPR
VICAP-CPR
1 other identifier
observational
1,000
8 countries
9
Brief Summary
The VICAP-CPR study investigates whether doctors and nurses working in Intensive Care can determine neurological outcome and future quality of life after six months in patients treated for cardiac arrest outside the hospital based on clinical assessment in the first 24 hours after admission to Intensive Care. To conduct this study, the results of the questionnaire offered to Intensive Care doctors and nurses regarding the estimation of long-term neurological outcome and quality of life will be compared with the neurological outcome and quality of life as recorded in the STEPCARE study (NCT 05564754). The aim of the international STEPCARE study is to determine the best combination of post-resuscitation care to favourably influence survival and neurological outcome in patients treated for cardiac arrest outside hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2025
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 18, 2025
CompletedFirst Submitted
Initial submission to the registry
June 10, 2025
CompletedFirst Posted
Study publicly available on registry
June 18, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2026
June 18, 2025
June 1, 2025
1.6 years
June 10, 2025
June 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Composite endpoint of survival, good functional outcome and good quality of life 6 months after OHCA
Good functional outcome defined as modified Rankin scale 0 - 3; quality of life based on EuroQol-VAS
6 months after return of spontaneous circulation
Secondary Outcomes (1)
Assessment of a likely poor neurological outcome based on the multimodal ICU neuroprognostication as performed in the Stepcare study NCT 05564754
More than 72 hours after randomisation in the Stepcare study NCT 05564754
Study Arms (1)
Nurses and doctors working in Intensive Care Units
Eligibility Criteria
The study population are doctors and nurses working in an Intensive Care Unit treating a patient included in the STEPCARE study (NCT 05564754) during the first 24 hours after admission to Intensive Care
You may qualify if:
- Doctors and nurses working in the Intensive Care Unit treating patients included in the STEPCARE study (NCT 05564754)
You may not qualify if:
- Doctors and nurses who do not have a direct treatment relationship with a patient included in the STEPCARE study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (9)
Medical University Innsbruck
Innsbruck, 6020, Austria
Ziekenhuis Oost-Limburg
Genk, 3600, Belgium
Ghent University Hospital
Ghent, 9000, Belgium
Helsinki University Central Hospital
Helsinki, 000290, Finland
Universitätsklinikum Lübeck
Lübeck, 23538, Germany
Policlinico San Martino
Genova, 16149, Italy
Wakefield Hospital
Wellington, 6021, New Zealand
King Abdulaziz Medical City
Riyadh, 22490, Saudi Arabia
Zürich University Hospital
Zurich, 8091, Switzerland
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 10, 2025
First Posted
June 18, 2025
Study Start
May 18, 2025
Primary Completion (Estimated)
December 30, 2026
Study Completion (Estimated)
December 30, 2026
Last Updated
June 18, 2025
Record last verified: 2025-06